跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 978 条关于
“aggression”
全部
978
临床试验
845
药物
0
机构
0
资讯
133
去年
Vafidemstat Phase IIa Results Published: Shows Promise in Treating Psychiatric Aggression
去年
CCL2/CCR2 Pathway Identified as Key Driver of Aggression in Double-Expressor DLBCL
去年
Oryzon Submits Phase III Protocol for Vafidemstat in Borderline Personality Disorder, Targeting First FDA-Approved Treatment
去年
Oryzon's Vafidemstat Receives FDA Support for Phase III Trial in Borderline Personality Disorder
去年
Oryzon Genomics Advances CNS and Oncology Programs, Prepares for Phase III Trial of Vafidemstat in BPD
去年
Synthetic THC Shows Promise in Reducing Agitation in Alzheimer's Patients
去年
Oryzon Genomics Advances CNS and Oncology Programs, Prepares for Phase III Trial of Vafidemstat in BPD
12个月前
Two Major NIH Grants Totaling $7.3 Million Fund Groundbreaking ADHD Medication Research
去年
Real-World Safety Analysis Reveals New Adverse Events for Fenfluramine in Rare Epilepsy Syndromes
去年
Cannabidiol linked to better social, executive function in tuberous sclerosis complex
第 1 页,共 14 页
上一页
下一页